Nurix Therapeutics Chief Legal Officer Christine Ring Reports Disposal of $431,903.8861 in Common Shares

• Nurix Therapeutics Chief Legal Officer Christine Ring sold 16,715 common shares on Nov. 2-3, 2026
• Nov. 2 sales comprised 9,527 shares at $25.7392 per share; another 1,075 shares sold at $26.7628
• The Nov. 3 sale totaled 6,113 shares at $25.8329 per share
• Ring also exercised employee stock options for 5,786 common shares at $8.72 per share on Nov. 2
• Direct common stock holdings stood at 4,406 shares following the transactions, according to the Form 4 dated Nov. 4, 2026

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817199-26-000036), on November 04, 2026, and is solely responsible for the information contained therein.